KEY TAKEAWAY: GSK and Novartis are just two pharma companies that have indicated they are cutting budgets at a time when healthcare is going through an enormous disruption.  Will these cuts limit DTC’s ability to evolve to meet the needs of the connected patients? Continue reading →